A2AR heterodimerizes with several other G-protein coupled receptors involved in striatal dysfunction and degeneration in HD; thus, A2AR could be considered a target for the development of pharmacological therapies for HD patients. The gene discussed is ADORA2A; the disease is Huntington disease.